Navigation Links
Irvine Pharmaceutical Services Introduces New Fill-and-Finish Subsidiary
Date:11/11/2008

IRVINE, Calif., Nov. 11 /PRNewswire/ -- Irvine Pharmaceutical Services, Inc., today announced the forthcoming January 2009 launch of Avrio Biopharmaceuticals. This venture is part of Irvine's overall growth strategy focused on improving its services and product offerings to current and potential clients.

Outfitted with an experienced team and state of the art equipment, Avrio Biopharma will provide a full range of formulation development and aseptic fill-and-finish services. It will be focused on developing optimized production processes and providing dependable filling, lyophilization and packaging capabilities for early phase clinical trial materials.

"We are very excited about this extension of our company," said Assad J. Kazeminy, CEO and Founder of Irvine Pharmaceutical Services. "Avrio will help round out our existing capabilities and its connection to Irvine will also make it possible to provide our clients with broader services via seamless partnership."

Since early 2007, Irvine Pharmaceutical Services, Inc., has experienced extensive growth and has made significant upgrades in its lab equipment and infrastructure. The opening of Avrio Biopharma is yet another step along the same growth lines, striving to better serve the needs of the company's clients and the pharmaceutical industry.

You can meet the team and learn more about Irvine and its new company, Avrio, at the AAPS Annual Meeting, booth 1707.

About Irvine

Irvine Pharmaceutical Services, Inc. is a fully integrated services provider that works with pharmaceutical, biotechnology and medical device companies through all phases of research and development. Founded in 1988 and committed to expansion and services that benefit its clients' priorities directly, Irvine is a fully cGMP compliant contract testing laboratory located in Irvine, CA. Visit http://www.irvinepharma.com or call (877) 445-6554.


'/>"/>
SOURCE Irvine Pharmaceutical Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Irvine Pharmaceutical Services Enhances Staff, Prepares for Innovative Expansion
2. Hoag Hospital Announces Agreement to Open Irvine Campus
3. Lucas Group to Host Military Hiring Conferences in Washington, DC; Irvine, CA and Dallas, TX
4. UC Irvine to lead statewide program on green materials research
5. UC Irvine researchers present latest findings at emergency medicine forum
6. UC-Irvine scientists present groundbreaking research at Society for Neuroscience conference
7. KV Pharmaceutical to File Form 12b-25 on November 12, 2008
8. Jazz Pharmaceuticals, Inc. to Announce Third Quarter Financial Results on November 13, 2008
9. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
10. MAP Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
11. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology: